Antibodies
Antibodies, Vol. 13, Pages 34: Characterization of a Trispecific PD-L1 Blocking Antibody That Exhibits EGFR-Conditional 4-1BB Agonist Activity Antibodies doi: 10.3390/antib13020034 Authors: Laura Rubio-Pérez Susana Frago Marta Compte Rocío Navarro Seandean L. Harwood Rodrigo Lázaro-Gorines Marina Gómez-Rosel Oana...
Antibodies, Vol. 13, Pages 33: Cross-Reactivity of N6AMT1 Antibodies with Aurora Kinase A: An Example of Antibody-Specific Non-Specificity Antibodies doi: 10.3390/antib13020033 Authors: Baiba Brūmele Evgeniia Serova Aleksandra Lupp Mihkel Suija Margit Mutso Reet Kurg Primary antibodies are one of the main tools...
Antibodies, Vol. 13, Pages 32: A Narrative Review of the State of the Art of CCR4-Based Therapies in Cutaneous T-Cell Lymphomas: Focus on Mogamulizumab and Future Treatments Antibodies doi: 10.3390/antib13020032 Authors: Corrado Zengarini Alba Guglielmo Martina Mussi Giovanna Motta Claudio Agostinelli Elena Sabattini Bianca...
Antibodies, Vol. 13, Pages 31: Fcγ-Receptor-Independent Controlled Activation of CD40 Canonical Signaling by Novel Therapeutic Antibodies for Cancer Therapy Antibodies doi: 10.3390/antib13020031 Authors: Karsten Beckmann Carmen Reitinger Xianglei Yan Anna Carle Eva Blümle Nicole Jurkschat Claudia Paulmann Sandra...
Antibodies, Vol. 13, Pages 30: Enhanced Characterization of Lysine-Linked Antibody Drug Conjugates Enabled by Middle-Down Mass Spectrometry and Higher-Energy Collisional Dissociation-Triggered Electron-Transfer/Higher-Energy Collisional Dissociation and Ultraviolet Photodissociation Antibodies doi: 10.3390/antib13020030 Authors: Eleanor Watts...
Antibodies, Vol. 13, Pages 29: Efficient Expression of Functionally Active Aflibercept with Designed N-glycans Antibodies doi: 10.3390/antib13020029 Authors: Tahereh Keshvari Stanislav Melnik Lin Sun Ali Niazi Farzaneh Aram Ali Moghadam Benjamin Kogelmann Gordana Wozniak-Knopp Somanath Kallolimath Amin Ramezani...
خوراک خبری خود را بسازید
آیا آماده هستید تا آن را اجرا کنید؟
بدون نیاز به کارت اعتباری، یک دوره آزمایشی 14 روزه را شروع کنید.